Labetalol Hydrochloride Injection
Product Images NDC 72266-103

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 72266-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Labetalol Carton)

Label for Labetalol Hydrochloride Injection, USP, 5 mg/mL (200 mg/40 mL) multi-dose vial by Fosun Pharma USA Inc. The label states intravenous injection use, prescription only, with additional content detailing ingredients and storage instructions. It includes barcodes and distributor information indicating product made in India.*

FDA Label Image

Labetalol Structural Formula (Labetalol Structural Formula)

Chemical structure of Labetalol Hydrochloride showing its molecular composition and bonding, including an aromatic ring, hydroxyl groups, amide group, and hydrochloride component.*

FDA Label Image

Vial (Labetalol Vial)

The label for Labetalol Hydrochloride Injection, USP shows a strength of 200 mg/40 mL (5 mg/mL) in a 40 mL multi-dose vial. The label indicates use for intravenous injection and is distributed by Fosun Pharma USA Inc. The label includes detailed ingredient information, storage instructions, and a barcode. The brand Novaplus+ is visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.